AT332368T - Selection of proteins by the rna protein fusions - Google Patents

Selection of proteins by the rna protein fusions

Info

Publication number
AT332368T
AT332368T AT98904574T AT98904574T AT332368T AT 332368 T AT332368 T AT 332368T AT 98904574 T AT98904574 T AT 98904574T AT 98904574 T AT98904574 T AT 98904574T AT 332368 T AT332368 T AT 332368T
Authority
AT
Austria
Prior art keywords
proteins
selection
protein fusions
rna protein
rna
Prior art date
Application number
AT98904574T
Other languages
German (de)
Inventor
Jack W Szostak
Richard W Roberts
Rihe Liu
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US3596397P priority Critical
Priority to US6449197P priority
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of AT332368T publication Critical patent/AT332368T/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26712662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT332368(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1062Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1048SELEX
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11Compounds covalently bound to a solid support
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
AT98904574T 1997-01-21 1998-01-14 Selection of proteins by the rna protein fusions AT332368T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US3596397P true 1997-01-21 1997-01-21
US6449197P true 1997-11-06 1997-11-06

Publications (1)

Publication Number Publication Date
AT332368T true AT332368T (en) 2006-07-15

Family

ID=26712662

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06013825T AT529509T (en) 1997-01-21 1998-01-14 Selection of proteins using rna protein fusions
AT98904574T AT332368T (en) 1997-01-21 1998-01-14 Selection of proteins by the rna protein fusions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06013825T AT529509T (en) 1997-01-21 1998-01-14 Selection of proteins using rna protein fusions

Country Status (17)

Country Link
US (5) US6258558B1 (en)
EP (2) EP0971946B1 (en)
JP (1) JP3692542B2 (en)
KR (1) KR100566859B1 (en)
CN (1) CN1238366C (en)
AT (2) AT529509T (en)
AU (1) AU738328B2 (en)
CA (1) CA2278786C (en)
DE (1) DE69835143T2 (en)
DK (2) DK0971946T3 (en)
ES (2) ES2373110T3 (en)
HK (1) HK1027577A1 (en)
IL (1) IL131016A (en)
PT (2) PT1712623E (en)
RU (1) RU2233878C2 (en)
TW (1) TW589323B (en)
WO (1) WO1998031700A1 (en)

Families Citing this family (348)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008200974B2 (en) * 1999-07-27 2012-05-03 Bristol-Myers Squibb Company Peptide acceptor ligation methods
EP0368684B2 (en) * 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
DE69730157D1 (en) * 1996-10-17 2004-09-09 Mitsubishi Chem Corp Molecule which brings together genotype and phenotype and its applications
US8207093B2 (en) 1997-01-21 2012-06-26 The General Hospital Corporation Selection of proteins using RNA-protein fusions
US6261804B1 (en) * 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
DE69837453T2 (en) 1997-07-07 2007-12-20 Medical Research Council An in vitro sorting procedure
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
US20070166741A1 (en) 1998-12-14 2007-07-19 Somalogic, Incorporated Multiplexed analyses of test samples
WO1999051773A1 (en) * 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
US6440695B1 (en) 1998-04-17 2002-08-27 Whitehead Institute For Biomedical Research Method for producing diverse libraries of encoded polypeptides
US20030170820A1 (en) * 1998-05-08 2003-09-11 Gregory Coia Continuous in- vitro evolution
JP4240574B2 (en) * 1998-05-15 2009-03-18 三菱化学株式会社 Protein labeling composition and protein labeling method
US6287765B1 (en) * 1998-05-20 2001-09-11 Molecular Machines, Inc. Methods for detecting and identifying single molecules
AU2004200998B2 (en) * 1998-08-17 2007-01-11 Compound Therapeutics, Inc. Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular RNA-protein fusion formation
DE69941193D1 (en) * 1998-08-17 2009-09-10 Bristol Myers Squibb Co Identification of compound protein interactions with libraries of coupled protein nucleic acid molecules
CA2334946A1 (en) * 1998-08-17 2000-02-24 Phylos, Inc. Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation
DK1137812T3 (en) * 1998-12-02 2007-05-21 Adnexus Therapeutics Inc DNA-protein fusions and uses thereof
WO2000034784A1 (en) * 1998-12-10 2000-06-15 Phylos, Inc. Protein scaffolds for antibody mimics and other binding proteins
US6818418B1 (en) * 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US7115396B2 (en) 1998-12-10 2006-10-03 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US20110136099A1 (en) 2007-01-16 2011-06-09 Somalogic, Inc. Multiplexed Analyses of Test Samples
US7855054B2 (en) * 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
AU2004242526B2 (en) * 1999-01-07 2007-08-30 United Kingdom Research And Innovation Optical Sorting Method
GB9900298D0 (en) * 1999-01-07 1999-02-24 Medical Res Council Optical sorting method
US6358713B1 (en) 1999-04-12 2002-03-19 Johns Hopkins University In vitro ribosome evolution
DE19923966C2 (en) * 1999-05-25 2003-04-24 Phylos Inc Detection system for the separation of sample components, its preparation and use
EP1187626A4 (en) 1999-06-01 2006-07-19 Compound Therapeutics Inc Methods for producing 5'-nucleic acid-protein conjugates
WO2001004265A2 (en) * 1999-07-12 2001-01-18 Phylos, Inc. C-terminal protein tagging
AT551352T (en) * 1999-07-27 2012-04-15 Squibb Bristol Myers Co Peptidakzeptorbindungsverfahren
US6436665B1 (en) 1999-08-27 2002-08-20 Phylos, Inc Methods for encoding and sorting in vitro translated proteins
AU7721100A (en) * 1999-10-01 2001-05-10 Zhongping Yu Compositions and methods for identifying polypeptides and nucleic acid molecules
WO2001083507A1 (en) * 2000-05-05 2001-11-08 Selegen Identification of polypeptides and nucleic acid molecules using linkage between dna and polypeptide
DE19959857C1 (en) * 1999-12-10 2001-06-28 Aventis Res & Tech Gmbh & Co Test system for detection of analytes and a method of making and using
AU2788101A (en) * 2000-01-11 2001-07-24 Maxygen, Inc. Integrated systems and methods for diversity generation and screening
DE60118527D1 (en) * 2000-01-24 2006-05-18 Compound Therapeutics Inc Sensitive and multiplexed diagnostic tests for protein analysis
US7022479B2 (en) * 2000-01-24 2006-04-04 Compound Therapeutics, Inc. Sensitive, multiplexed diagnostic assays for protein analysis
CA2399241A1 (en) * 2000-02-24 2001-08-30 Phylos, Inc. Improved methods for generating catalytic proteins
US6489106B1 (en) * 2000-03-10 2002-12-03 Nec Research Institute, Inc. Control of the expression of anchored genes using micron scale heaters
US7410761B2 (en) 2000-05-19 2008-08-12 Proteonova, Inc. System for rapid identification and selection of nucleic acids and polypeptides, and method thereof
US6962781B1 (en) 2000-05-19 2005-11-08 Proteonova, Inc. In vitro evolution of nucleic acids and encoded polypeptide
AU6177101A (en) * 2000-05-19 2001-12-03 Richard B Williams In vitro evolution of nucleic acids and encoded polypeptide
US20040229271A1 (en) 2000-05-19 2004-11-18 Williams Richard B. Compositions and methods for the identification and selection of nucleic acids and polypeptides
ES2319866T3 (en) 2000-06-29 2009-05-14 Abbott Laboratories Antibodies of dual specificity and methods of manufacture and use.
DE10033194C2 (en) * 2000-07-07 2002-07-18 Aventis Res & Tech Gmbh & Co Bioprobes and their use
US20030143612A1 (en) * 2001-07-18 2003-07-31 Pointilliste, Inc. Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
DK1309861T3 (en) * 2000-08-15 2006-10-23 Discerna Ltd Functional protein arrays
DE10041238A1 (en) * 2000-08-22 2002-03-07 Aventis Res & Tech Gmbh & Co A method for identifying specific cleavable peptide, and use of such peptide sequences
WO2002016625A2 (en) 2000-08-25 2002-02-28 Basf Plant Science Gmbh Plant polynucleotides encoding prenyl proteases
AU1325102A (en) 2000-10-16 2002-04-29 Phylos Inc Protein scaffolds for antibody mimics and other binding proteins
US6841359B2 (en) 2000-10-31 2005-01-11 The General Hospital Corporation Streptavidin-binding peptides and uses thereof
US20020164611A1 (en) * 2000-11-15 2002-11-07 Bamdad R. Shoshana Oligonucleotide identifiers
WO2002046395A1 (en) 2000-12-07 2002-06-13 Keio University C-terminal modified protein and process for producing the same, modifying agent and translation template to be used in produfing c-terminal modified protein, and method of detecting protein interaction with the use of c-termial modified protein
JP4963142B2 (en) * 2000-12-14 2012-06-27 学校法人慶應義塾 Genotype-phenotype mapping molecule and its constituents, and method for producing and using mapping molecule
US7262054B2 (en) * 2002-01-22 2007-08-28 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US9234187B2 (en) * 2001-01-22 2016-01-12 Sangamo Biosciences, Inc. Modified zinc finger binding proteins
EP1360490B1 (en) 2001-01-23 2011-12-21 President and Fellows of Harvard College Nucleic-acid programmable protein arrays
US7070928B2 (en) * 2001-03-19 2006-07-04 President And Fellows Of Harvard College Evolving new molecular function
AU2002307106A1 (en) * 2001-04-02 2002-10-15 University Of Washington Dynamic action reference tools
AU2002256076A1 (en) * 2001-04-10 2002-10-28 Interlock Industries, Inc. Water based adhesive
US20060008844A1 (en) 2004-06-17 2006-01-12 Avidia Research Institute c-Met kinase binding proteins
JP2008099700A (en) * 2001-05-11 2008-05-01 National Institute Of Advanced Industrial & Technology Method of forming stable complex of transcription product of dna encoding arbitrary peptide with translation product, nucleic acid construct to be used in the method, complex formed by the method, and screening of functional protein and mrna or dna encoding the protein using the method
AT414769T (en) 2002-03-15 2008-12-15 Nuevolution As An improved method for synthesis of mattress-related molecules
US7727713B2 (en) 2001-06-20 2010-06-01 Nuevolution A/S Templated molecules and methods for using such molecules
EP2305808B1 (en) * 2001-06-20 2016-03-02 Nuevolution A/S Templated molecules and methods for using such molecules
US20060234231A1 (en) * 2001-06-20 2006-10-19 Nuevolution A/S Microarrays displaying encoded molecules
WO2003078627A2 (en) * 2002-03-15 2003-09-25 Nuevolution A/S A building block capable of functional entity transfer to nucleophil
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
EP1419274A4 (en) * 2001-07-31 2006-02-08 Phylos Inc Modular assembly of nucleic acid-protein fusion multimers
US7172905B2 (en) * 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
DE10147074A1 (en) * 2001-09-25 2003-05-08 Beru Ag A method of operating a multiple heating elements multistage electric heater
GB0127564D0 (en) 2001-11-16 2002-01-09 Medical Res Council Emulsion compositions
WO2003072542A2 (en) 2001-11-20 2003-09-04 Duke University Interfacial biomaterials
WO2003045975A2 (en) * 2001-11-27 2003-06-05 Compound Therapeutics, Inc. Solid-phase immobilization of proteins and peptides
DE20200926U1 (en) * 2002-01-23 2002-04-18 Hegenscheidt Mfd Gmbh & Co Kg Fixed roll apparatus of a hard-rolling machine for crankshafts
AU2003217379A1 (en) * 2002-02-15 2003-09-09 Somalogic, Inc. Methods and reagents for detecting target binding by nucleic acid ligands
WO2003078446A2 (en) * 2002-03-15 2003-09-25 Nuevolution A/S A building block forming a c-c or a c-hetero atom bond upon reaction
NO20021298L (en) * 2002-03-15 2003-09-16 Bjoern H Lindqvist Methods for peptide and protein detection in nucleic acid chip arrays
WO2003078050A2 (en) * 2002-03-15 2003-09-25 Nuevolution A/S A building block forming a c-c bond upon reaction
US20030235852A1 (en) * 2002-04-19 2003-12-25 Roberts Richard W. Nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues, and methods of making same using peptide modifying agents
US20030198973A1 (en) * 2002-04-23 2003-10-23 The Molecular Sciences Institute, Inc. Chimeric fusion molecule for analyte detection and quantitation
US20060073481A1 (en) * 2002-04-23 2006-04-06 The Molecular Sciences Institute Formation and use of site specific nucleic acid coupled binding polypeptides
US20030198967A1 (en) * 2002-04-23 2003-10-23 Matson Robert S. Multi-functional microarrays and methods
EP2500729A1 (en) * 2002-07-05 2012-09-19 The University of Chicago Characterization of biochips containing self-assembled monolayers
JP4836451B2 (en) * 2002-07-18 2011-12-14 メルス ベー ヴェー Recombinant production of antibody mixtures
WO2004013070A2 (en) 2002-08-01 2004-02-12 Nuevolution A/S Multi-step synthesis of templated molecules
JP4657919B2 (en) * 2002-08-19 2011-03-23 プレジデント アンド フェローズ オブ ハーバード カレッジ Evolving new molecular functions
US8017323B2 (en) * 2003-03-26 2011-09-13 President And Fellows Of Harvard College Free reactant use in nucleic acid-templated synthesis
US20040043384A1 (en) * 2002-08-28 2004-03-04 Oleinikov Andrew V. In vitro protein translation microarray device
US7361635B2 (en) * 2002-08-29 2008-04-22 Sangamo Biosciences, Inc. Simultaneous modulation of multiple genes
US7354750B2 (en) * 2002-10-18 2008-04-08 Promega Corporation Methods for separating molecules
AU2011226815B2 (en) * 2002-10-30 2014-09-25 Nuevolution A/S Enzymatic encoding
DK2348125T3 (en) * 2002-10-30 2017-10-02 Nuevolution As Process for the synthesis of a bifunctional complex
US9121110B2 (en) 2002-12-19 2015-09-01 Nuevolution A/S Quasirandom structure and function guided synthesis methods
US7083948B1 (en) * 2002-12-24 2006-08-01 Immunex Corporation Polypeptide purification reagents and methods for their use
EP2145955B1 (en) 2003-01-29 2012-02-22 454 Life Sciences Corporation Bead emulsion nucleic acid amplification
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
KR100858081B1 (en) * 2003-02-14 2008-09-10 삼성전자주식회사 Apparatus for coding gene information and method of the same
US20070026397A1 (en) * 2003-02-21 2007-02-01 Nuevolution A/S Method for producing second-generation library
EP1597394A2 (en) * 2003-02-21 2005-11-23 Per-Ola Freskgard A method for obtaining structural information about an encoded molecule
WO2005090566A2 (en) 2004-03-22 2005-09-29 Nuevolution A/S Ligational encoding using building block oligonucleotides
US7915201B2 (en) 2003-03-20 2011-03-29 Nuevolution A/S Ligational encoding of small molecules
WO2004087730A2 (en) * 2003-03-27 2004-10-14 The Johns Hopkins University Method for producing diverse libraries of encoded polymers
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20050079546A1 (en) * 2003-05-01 2005-04-14 Dasa Lipovsek Serum albumin scaffold-based proteins and uses thereof
CA2527694C (en) 2003-05-30 2015-07-14 Hendricus Renerus Jacobus Mattheus Hoogenboom Fab library for the preparation of anti vegf and anti rabies virus fabs
WO2004110964A2 (en) * 2003-06-16 2004-12-23 Nuevolution A/S Encoded molecules by translation (emt)
WO2005010145A2 (en) 2003-07-05 2005-02-03 The Johns Hopkins University Method and compositions for detection and enumeration of genetic variations
CA2536238C (en) 2003-08-18 2015-04-07 Medimmune, Inc. Humanization of antibodies
EP1670939B1 (en) * 2003-09-18 2009-11-04 Nuevolution A/S A method for obtaining structural information concerning an encoded molecule and method for selecting compounds
CA2552435A1 (en) * 2003-12-05 2005-06-23 Compound Therapeutics, Inc. Inhibitors of type 2 vascular endothelial growth factor receptors
US20080220049A1 (en) * 2003-12-05 2008-09-11 Adnexus, A Bristol-Myers Squibb R&D Company Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
NZ548828A (en) 2004-01-20 2009-07-31 Merus B V Mixtures of binding proteins
WO2005078122A2 (en) * 2004-02-17 2005-08-25 Nuevolution A/S Method for enrichment involving elimination by mismatch hybridisation
EP1774334B1 (en) * 2004-08-03 2017-10-04 Becton, Dickinson and Company Use of magnetic material to direct isolation of compounds and fractionation of multipart samples
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
DK1836302T3 (en) * 2004-12-23 2010-08-02 Ge Healthcare Bio Sciences Ligation-based RNA amplification
EP3431503A1 (en) * 2005-01-12 2019-01-23 Proteonova, Inc. Method for making targeted therapeutic agents
US10206998B2 (en) 2005-01-12 2019-02-19 Proteonova, Inc. Modular targeted therapeutic agents and methods of making same
AU2006227377B2 (en) 2005-03-18 2013-01-31 Medimmune, Llc Framework-shuffling of antibodies
WO2007011722A2 (en) 2005-07-15 2007-01-25 President And Fellows Of Harvard College Reaction discovery system
SG2014010029A (en) 2005-08-19 2014-08-28 Abbott Lab Dual variable domain immunoglobin and uses thereof
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
EP2500353A3 (en) 2005-08-19 2012-10-10 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
ES2542501T3 (en) 2005-09-30 2015-08-06 Abbvie Deutschland Gmbh & Co Kg Protein binding domains of the protein family of repulsive targeting molecules (RGM) and functional fragments thereof, as well as their use
US7705138B2 (en) * 2005-11-11 2010-04-27 Vertex Pharmaceuticals Incorporated Hepatitis C virus variants
EP1785434A1 (en) 2005-11-11 2007-05-16 Ludwig-Maximilians-Universität München Targeting and tracing of antigens in living cells
RU2008123606A (en) 2005-11-11 2009-12-20 Вертекс Фармасьютикалз, Инк (Us) Hepatitis C Virus Options
KR20080079643A (en) 2005-11-16 2008-09-01 암브룩스, 인코포레이티드 Methods and compositions comprising non-natural amino acids
AU2006320392B2 (en) 2005-11-30 2013-01-17 AbbVie Deutschland GmbH & Co. KG Monoclonal antibodies against amyloid beta protein and uses thereof
ES2524984T3 (en) 2005-11-30 2014-12-16 Abbvie Inc. Anti-globulomer antibodies to? Antigen-binding portions thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods for producing said antibodies, compositions comprising said antibodies, uses of said antibodies, and methods for using said antibodies
EP1957644B1 (en) 2005-12-01 2010-12-01 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
US20080305559A1 (en) * 2005-12-15 2008-12-11 Gualberto Gonzalez-Sapienza Non-Competitive Immunoassays to Detect Small Molecules
EP2363205A3 (en) 2006-01-11 2014-06-04 Raindance Technologies, Inc. Microfluidic Devices And Methods Of Use In The Formation And Control Of Nanoreactors
CA2634987C (en) * 2006-01-17 2017-01-03 Somalogic, Incorporated Multiplexed analyses of test samples
MX2008009792A (en) 2006-02-01 2008-09-01 Arana Therapeutics Ltd Domain antibody construct.
WO2007092777A2 (en) * 2006-02-02 2007-08-16 Wyeth Cloning, characterization, and application of tnfrsf19 in neurological disorders
US7749957B2 (en) 2006-04-06 2010-07-06 E.I. Du Pont De Nemours And Company Clay-binding peptides and methods of use
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP3031918B1 (en) 2006-05-11 2018-03-14 Raindance Technologies Inc. Microfluidic devices
US8178316B2 (en) 2006-06-29 2012-05-15 President And Fellows Of Harvard College Evaluating proteins
US7572618B2 (en) 2006-06-30 2009-08-11 Bristol-Myers Squibb Company Polynucleotides encoding novel PCSK9 variants
EP2044219B1 (en) 2006-06-30 2013-05-22 DiscoveRx Corporation Detectable nucleic acid tag
JP2009545747A (en) * 2006-08-02 2009-12-24 カリフォルニア インスティチュート オブ テクノロジー Method and system for detecting and / or sorting targets
WO2008021123A1 (en) 2006-08-07 2008-02-21 President And Fellows Of Harvard College Fluorocarbon emulsion stabilizing surfactants
AU2007351514B2 (en) 2006-09-08 2013-02-21 Abbvie Inc. Interleukin -13 binding proteins
US20090252745A1 (en) * 2006-09-15 2009-10-08 Duke University Amino acids in the HCV core polypeptide domain 3 and correlation with steatosis
EP2727936B1 (en) 2006-11-22 2016-09-07 Bristol-Myers Squibb Company Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2114443A4 (en) 2006-12-29 2011-08-10 Abbott Lab Dual-specific il-1a/ il-1b antibodies
AT516814T (en) 2007-02-02 2011-08-15 Squibb Bristol Myers Co 10fn3 domain for the treatment of diseases accompanied by unwanted angiogenesis
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
CA2677804C (en) 2007-02-12 2017-03-14 Proteonova, Inc. Generation of library of soluble random polypeptides linked to mrna
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US7951559B2 (en) * 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7829311B2 (en) 2007-07-25 2010-11-09 E.I. Du Pont De Nemours And Company Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
US7678883B2 (en) 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
US8680019B2 (en) * 2007-08-10 2014-03-25 Protelica, Inc. Universal fibronectin Type III binding-domain libraries
US8470966B2 (en) 2007-08-10 2013-06-25 Protelica, Inc. Universal fibronectin type III binding-domain libraries
WO2009023184A2 (en) * 2007-08-10 2009-02-19 Protelix, Inc. Universal fibronectin type iii binding-domain libraries
EP2193146B1 (en) 2007-09-14 2016-05-25 Adimab, LLC Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
US7794963B2 (en) 2007-11-02 2010-09-14 E.I. Du Pont De Nemours And Company Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
EP2209491B1 (en) 2007-11-02 2015-10-28 Novartis AG Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)
US8906700B2 (en) 2007-11-06 2014-12-09 Ambergen, Inc. Methods and compositions for phototransfer
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
SG10201604258YA (en) 2007-11-30 2016-07-28 Abbvie Biotechnology Ltd Anti-tnf antibody formulations
WO2009075773A2 (en) * 2007-12-07 2009-06-18 Goldstein Steven A Identification of toxin ligands
EP2247615B1 (en) 2008-02-14 2014-07-30 Bristol-Myers Squibb Company Targeted therapeutics based on engineered proteins that bind egfr
US8962803B2 (en) 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
WO2009114815A1 (en) * 2008-03-13 2009-09-17 Dyax Corp Libraries of genetic packages comprising novel hc cdr3 designs
EP2269064B1 (en) 2008-03-27 2016-11-30 Promega Corporation Protein labeling with cyanobenzothiazole conjugates
US9388510B2 (en) * 2008-04-24 2016-07-12 Dyax Corp. Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs
CN108467431A (en) 2008-04-25 2018-08-31 戴埃克斯有限公司 For the antibody and application thereof of FCRN
MX2010011955A (en) 2008-04-29 2011-01-21 Abbott Lab Dual variable domain immunoglobulins and uses thereof.
EP2285953B1 (en) * 2008-05-02 2015-01-14 Cellscript, Llc Rna polyphosphatase compositions, kits, and uses thereof
CA2723219A1 (en) 2008-05-09 2009-11-12 Abbott Gmbh & Co. Kg Antibodies to receptor of advanced glycation end products (rage) and uses thereof
PE20091931A1 (en) 2008-05-22 2009-12-31 Squibb Bristol Myers Co Frame domain proteins based multivalent fibronectin
EP3002299A1 (en) 2008-06-03 2016-04-06 AbbVie Inc. Dual variable domain immunoglobulins and uses thereof
KR20110016959A (en) 2008-06-03 2011-02-18 아보트 러보러터리즈 Dual variable domain immunoglobulins and uses thereof
JP5988580B2 (en) 2008-06-30 2016-09-07 エスバテック − ア ノバルティス カンパニー エルエルシー Functional polypeptide
CN104829718A (en) 2008-07-08 2015-08-12 艾伯维公司 Prostaglandin E2 binding proteins and uses thereof
MX2010014574A (en) 2008-07-08 2011-04-27 Abbott Lab Prostaglandin e2 dual variable domain immunoglobulins and uses thereof.
EP2316030B1 (en) * 2008-07-25 2019-08-21 Wagner, Richard W. Protein screeing methods
CA2736430A1 (en) * 2008-09-30 2010-04-08 Abbott Laboratories Improved antibody libraries
WO2010045315A1 (en) 2008-10-14 2010-04-22 Dyax Corp. Use of igf-ii/igf-iie binding for the treatment and prevention of systemic sclerosis associated pulmonary fibrosis
TWI496582B (en) 2008-11-24 2015-08-21 Squibb Bristol Myers Co Bispecific egfr/igfir binding molecules
US8287845B2 (en) * 2008-12-18 2012-10-16 E I Du Pont De Nemours And Company Hair-binding peptides
US20100158822A1 (en) 2008-12-18 2010-06-24 E .I. Du Pont De Nemours And Company Peptides that bind to silica-coated particles
US8697654B2 (en) 2008-12-18 2014-04-15 E I Du Pont De Nemours And Company Peptide linkers for effective multivalent peptide binding
US20100158837A1 (en) 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Iron oxide-binding peptides
US20100158846A1 (en) * 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Hair-binding peptides
CN101768213B (en) 2008-12-30 2012-05-30 中国科学院遗传与发育生物学研究所 Protein related to plant tillering number and coding gene and application thereof
NZ594420A (en) 2009-02-13 2013-06-28 Chem Inc X Methods of creating and screening dna-encoded libraries
CN101817879A (en) 2009-02-26 2010-09-01 中国科学院遗传与发育生物学研究所 Metallothionein and encoding gene and application thereof
PE20121094A1 (en) 2009-03-05 2012-09-13 Abbvie Inc Binding proteins IL-17
BRPI1014677A2 (en) * 2009-03-30 2016-04-12 Du Pont peptide-based systems for dispensing cosmetic agents
US8481678B2 (en) 2009-03-30 2013-07-09 E I Du Pont De Nemours And Company Peptide-based tooth whitening reagents
US8067201B2 (en) 2009-04-17 2011-11-29 Bristol-Myers Squibb Company Methods for protein refolding
WO2010124157A1 (en) 2009-04-24 2010-10-28 Ambit Biosciences Corporation Cellular assay employing detectable protein
WO2010127186A1 (en) 2009-04-30 2010-11-04 Prognosys Biosciences, Inc. Nucleic acid constructs and methods of use
BR112012004546A2 (en) 2009-08-29 2016-11-29 Abbott Lab "dll4-ligand protein therapy"
EP2473524A4 (en) 2009-09-01 2013-05-22 Abbott Lab Dual variable domain immunoglobulins and uses thereof
US20110082054A1 (en) * 2009-09-14 2011-04-07 Dyax Corp. Libraries of genetic packages comprising novel hc cdr3 designs
WO2011044133A2 (en) * 2009-10-05 2011-04-14 Opsonic Therapeutics Inc. High affinity adaptor molecules for redirecting antibody specifity
AR078651A1 (en) 2009-10-15 2011-11-23 Abbott Lab Immunoglobulins Dual variable domain and uses thereof
JP5174971B2 (en) 2009-10-22 2013-04-03 ペプチドリーム株式会社 RAPID display method in peptide translation synthesis
UY32979A (en) 2009-10-28 2011-02-28 Abbott Lab Immunoglobulins Dual variable domain and uses thereof
EP3434769A1 (en) 2009-10-30 2019-01-30 Novartis AG Universal fibronectin type iii bottom-side binding domain libraries
US8420083B2 (en) 2009-10-31 2013-04-16 Abbvie Inc. Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
WO2011054893A2 (en) 2009-11-05 2011-05-12 Novartis Ag Biomarkers predictive of progression of fibrosis
WO2011058087A1 (en) 2009-11-11 2011-05-19 Gentian As Immunoassay for assessing related analytes of different origin
MX2012006397A (en) 2009-12-02 2012-11-30 Amgen Inc Binding proteins that bind to human fgfr1c, human î²-klotho and both human fgfr1c and humanî²-klotho.
WO2011071943A1 (en) * 2009-12-07 2011-06-16 Prognosys Biosciences, Inc. Peptide display arrays
CA2780069C (en) 2009-12-08 2018-07-17 Abbott Gmbh & Co. Kg Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
WO2011085103A2 (en) 2010-01-06 2011-07-14 Dyax Corp. Plasma kallikrein binding proteins
US20120296403A1 (en) 2010-02-10 2012-11-22 Novartis Ag Methods and compounds for muscle growth
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
EP3392349A1 (en) 2010-02-12 2018-10-24 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
EP2536757B1 (en) 2010-02-18 2015-03-25 Bristol-Myers Squibb Company Fibronectin based scaffold domain proteins that bind il-23
KR101853278B1 (en) 2010-03-02 2018-05-02 애브비 인코포레이티드 Therapeutic dll4 binding proteins
ES2555106T3 (en) 2010-04-05 2015-12-29 Prognosys Biosciences, Inc. Spatially coded biological assays
DK2558491T3 (en) 2010-04-13 2018-10-15 Squibb Bristol Myers Co Fibronectin-based Scaffold domain proteins that bind PCSK9
CA2796339A1 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
TW201138808A (en) 2010-05-03 2011-11-16 Squibb Bristol Myers Co Serum albumin binding molecules
UY33386A (en) 2010-05-14 2011-12-30 Abbott Laboratoires Binding proteins yl-1
EP3091028A1 (en) 2010-05-26 2016-11-09 Bristol-Myers Squibb Company Fibronectin based scaffold proteins having improved stability
WO2012006500A2 (en) 2010-07-08 2012-01-12 Abbott Laboratories Monoclonal antibodies against hepatitis c virus core protein
UY33492A (en) 2010-07-09 2012-01-31 Abbott Lab Immunoglobulins Dual variable domain and uses thereof
CA2805875A1 (en) 2010-07-16 2012-01-19 Adimab, Llc Libraries comprising segmental pools, and methods for their preparation and use
EP2598529A2 (en) 2010-07-30 2013-06-05 Novartis AG Fibronectin cradle molecules and libraries thereof
BR112013002578A2 (en) 2010-08-03 2019-05-14 Abbvie Inc immunoglobulins dual variable domain and uses the same
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CA2808187A1 (en) 2010-08-14 2012-02-23 Abbvie Inc. Amyloid-beta binding proteins
JP6121903B2 (en) 2010-08-19 2017-04-26 ゾエティス・ベルジャム・エス・アー Anti-NGF antibodies and uses thereof
BR112013004581A2 (en) 2010-08-26 2017-06-27 Abbvie Inc dual variable domain immunoglobulins and their uses
EP2622103B1 (en) 2010-09-30 2018-09-12 Raindance Technologies, Inc. Sandwich assays in droplets
EP2857413A1 (en) 2010-10-01 2015-04-08 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
WO2012052391A1 (en) 2010-10-19 2012-04-26 Glaxo Group Limited Polypeptide with jmjd3 catalytic activity
SG189957A1 (en) 2010-11-05 2013-06-28 Morphotek Inc Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
JP6206943B2 (en) * 2010-12-03 2017-10-04 国立大学法人 東京大学 Method for producing peptide library, peptide library, and screening method
CN103328648B (en) 2010-12-03 2015-11-25 国立大学法人东京大学 Peptides and peptide libraries with a stable secondary structure and a manufacturing method thereof
US20120275996A1 (en) 2010-12-21 2012-11-01 Abbott Laboratories IL-1 Binding Proteins
PE20141060A1 (en) 2010-12-21 2014-09-26 Abbvie Inc Immunoglobulins Dual variable domain bispecific IL-1 alpha and beta and their use
WO2012088006A1 (en) 2010-12-22 2012-06-28 Bristol-Myers Squibb Company Fibronectin based scaffold domain proteins that bind il-23
DE102010056289A1 (en) 2010-12-24 2012-06-28 Geneart Ag Process for the preparation of reading frame correct fragment libraries
EP3412778A1 (en) 2011-02-11 2018-12-12 Raindance Technologies, Inc. Methods for forming mixed droplets
US9150852B2 (en) 2011-02-18 2015-10-06 Raindance Technologies, Inc. Compositions and methods for molecular labeling
WO2012125652A2 (en) 2011-03-14 2012-09-20 University Of Southern California Antibody and antibody mimetic for visualization and ablation of endogenous proteins
WO2012135805A2 (en) 2011-03-31 2012-10-04 modeRNA Therapeutics Delivery and formulation of engineered nucleic acids
WO2012139110A2 (en) 2011-04-08 2012-10-11 Prognosys Biosciences, Inc. Peptide constructs and assay systems
SI2697257T1 (en) 2011-04-13 2017-02-28 Bristol-Myers Squibb Company Fc fusion proteins comprising novel linkers or arrangements
AU2012249158B2 (en) 2011-04-28 2017-06-29 Department Of Veterans Affairs Identification of polynucleotides associated with a sample
WO2012158739A1 (en) 2011-05-17 2012-11-22 Bristol-Myers Squibb Company Improved methods for the selection of binding proteins
CN103890582A (en) 2011-06-02 2014-06-25 麻省理工学院 DsRNA/DNA hybrid genome replication intermediate of metakaryotic stem cells
AU2012262007B2 (en) 2011-06-02 2017-06-22 Dyax Corp. Fc receptor binding proteins
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP2742153B1 (en) 2011-08-01 2018-09-05 The General Hospital Corporation Protein and peptide libraries
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
AU2012352180A1 (en) 2011-12-16 2014-07-31 Moderna Therapeutics, Inc. Modified nucleoside, nucleotide, and nucleic acid compositions
KR20190099538A (en) 2011-10-03 2019-08-27 모더나 세라퓨틱스, 인코포레이티드 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
SG11201401791WA (en) 2011-10-24 2014-08-28 Abbvie Inc Immunobinders directed against sclerostin
US9803009B2 (en) 2011-10-24 2017-10-31 Abbvie Inc. Immunobinders directed against TNF
US9522951B2 (en) 2011-10-31 2016-12-20 Bristol-Myers Squibb Company Fibronectin binding domains with reduced immunogenicity
WO2013085972A1 (en) 2011-12-05 2013-06-13 X-Body, Inc. Pdgf receptor beta binding polypeptides
MX357708B (en) 2011-12-14 2018-07-20 Abbvie Deutschland Composition and method for the diagnosis and treatment of iron-related disorders.
WO2013090633A2 (en) 2011-12-14 2013-06-20 AbbVie Deutschland GmbH & Co. KG Composition and method for the diagnosis and treatment of iron-related disorders
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
BR112014015851A2 (en) 2011-12-30 2019-09-24 Abbvie Inc double specific binding proteins directed against il-13 and / or il-17
BR112014018592A2 (en) 2012-01-27 2017-07-04 Abbvie Deutschland composition and method for the diagnosis and treatment of diseases associated with neuronal degeneration
GB2500243A (en) * 2012-03-15 2013-09-18 Isogenica Ltd Identifying members of immobilised peptide libraries comprising protein-DNA complexes
US20150064235A1 (en) 2012-03-30 2015-03-05 Moderna Therapeutics, Inc. Modified polynucleotides
US9878056B2 (en) 2012-04-02 2018-01-30 Modernatx, Inc. Modified polynucleotides for the production of cosmetic proteins and peptides
EP2833921A2 (en) 2012-04-02 2015-02-11 Moderna Therapeutics, Inc. Modified polynucleotides for the production of secreted proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
SG11201406770WA (en) 2012-04-20 2014-11-27 Merus B V Methods and means for the production of ig-like molecules
CA2873511A1 (en) 2012-05-17 2013-11-21 Ra Pharmaceuticals, Inc. Peptide and peptidomimetic inhibitors
JP2015521461A (en) 2012-06-06 2015-07-30 ゾエティス・エルエルシー Caninized anti-NGF antibody and method thereof
AR091755A1 (en) 2012-07-12 2015-02-25 Abbvie Inc Binding proteins yl-1
US8853154B2 (en) 2012-09-13 2014-10-07 Bristol-Myers Squibb Company Fibronectin based scaffold domain proteins that bind to myostatin
KR20190107184A (en) 2012-11-01 2019-09-18 애브비 인코포레이티드 Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof
JP6144355B2 (en) 2012-11-26 2017-06-07 モデルナティエックス インコーポレイテッドModernaTX,Inc. Chemically modified mRNA
US9550986B2 (en) 2012-12-21 2017-01-24 Abbvie Inc. High-throughput antibody humanization
US20160068835A1 (en) 2013-01-30 2016-03-10 Peptidream Inc. Flexible display method
US20150361159A1 (en) 2013-02-01 2015-12-17 Bristol-Myers Squibb Company Fibronectin based scaffold proteins
WO2014126884A1 (en) 2013-02-12 2014-08-21 Bristol-Myers Squibb Company High ph protein refolding methods
EP2962100A1 (en) 2013-02-28 2016-01-06 Caprion Proteomics Inc. Tuberculosis biomarkers and uses thereof
US20160152686A1 (en) 2013-03-13 2016-06-02 Bristol-Myers Squibb Company Fibronectin based scaffold domains linked to serum albumin or moiety binding thereto
EP2970947A4 (en) 2013-03-14 2016-10-12 Abbott Lab Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection
MX362075B (en) 2013-03-14 2019-01-07 Abbott Lab Hcv antigen-antibody combination assay and methods and compositions for use therein.
EP2971046A4 (en) 2013-03-14 2016-11-02 Abbott Lab Hcv core lipid binding domain monoclonal antibodies
US10132816B2 (en) 2013-03-14 2018-11-20 Beth Israel Deaconess Medical Center, Inc. Measurement of FGF21 as a biomarker of fructose metabolism
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
US9469686B2 (en) 2013-03-15 2016-10-18 Abbott Laboratories Anti-GP73 monoclonal antibodies and methods of obtaining the same
EP2970459A2 (en) 2013-03-15 2016-01-20 AbbVie Inc. Dual specific binding proteins directed against il-1beta and il-17
JP6583794B2 (en) 2013-05-20 2019-10-02 バイオベンチャーズ・リミテッド・ライアビリティ・カンパニーBioVentures, LLC GEP5 model for multiple myeloma
WO2014197885A2 (en) 2013-06-07 2014-12-11 Duke University Inhibitors of complement factor h
CA2916660A1 (en) 2013-06-25 2014-12-31 Prognosys Biosciences, Inc. Spatially encoded biological assays using a microfluidic device
JP2016529884A (en) 2013-06-28 2016-09-29 エックス−ボディ インコーポレイテッド Target antigen search, phenotypic screening and their use for identification of target epitopes specific to target cells
CA2923029A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Chimeric polynucleotides
CN105705947B (en) 2013-09-23 2019-04-02 X博迪公司 For generating the method and composition of the bonding agent of confrontation cell surface antigen
WO2015051214A1 (en) 2013-10-03 2015-04-09 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
WO2015070037A2 (en) 2013-11-08 2015-05-14 Prognosys Biosciences, Inc. Polynucleotide conjugates and methods for analyte detection
GB201322692D0 (en) 2013-12-20 2014-02-05 Philochem Ag Production of encoded chemical libraries
WO2015120058A2 (en) 2014-02-05 2015-08-13 Molecular Templates, Inc. Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
AU2015231170B2 (en) 2014-03-20 2019-10-03 Bristol-Myers Squibb Company Serum albumin-binding fibronectin type III domains
SG11201607818WA (en) 2014-03-20 2016-10-28 Squibb Bristol Myers Co Stabilized fibronectin based scaffold molecules
WO2016123371A1 (en) 2015-01-28 2016-08-04 Ra Pharmaceuticals, Inc. Modulators of complement activity
BR112016029076A2 (en) 2014-06-12 2018-06-05 Ra Pharmaceuticals Inc complement activity modulation
CA2958200A1 (en) 2014-08-14 2016-02-18 Novartis Ag Treatment of cancer using a gfr alpha-4 chimeric antigen receptor
WO2016054312A1 (en) 2014-10-02 2016-04-07 Vertex Pharmaceuticals Incorporated Influenza a virus variants
CA2963070A1 (en) 2014-10-02 2016-04-07 Vertex Pharmaceuticals Incorporated Influenza a virus variants
EA201791167A1 (en) 2014-11-25 2017-11-30 Бристол-Маерс Сквибб Компани Methods and compositions for switching radioactive isotopom for biological preparations
WO2016094881A2 (en) 2014-12-11 2016-06-16 Abbvie Inc. Lrp-8 binding proteins
EP3061826A1 (en) 2015-02-27 2016-08-31 Novartis AG Flavivirus replicons
CN104774801A (en) * 2015-04-14 2015-07-15 云南农业大学 Nucleic acid-ribosome combination system construction method and application thereof
CA2983276A1 (en) 2015-04-24 2016-10-27 Viiv Healthcare Uk (No 5) Limited Polypeptides targeting hiv fusion
CN107810198A (en) 2015-05-29 2018-03-16 艾伯维公司 Anti-CD 40 antibodies and application thereof
TW201710286A (en) 2015-06-15 2017-03-16 艾伯維有限公司 Binding proteins against VEGF, PDGF, and/or their receptors
WO2017165742A1 (en) 2016-03-24 2017-09-28 Millennium Pharmaceuticals, Inc. Methods of treating gastrointestinal immune-related adverse events in anti-ctla4 anti-pd-1 combination treatments
EP3433275A1 (en) 2016-03-24 2019-01-30 Millennium Pharmaceuticals, Inc. Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments
KR20190015376A (en) 2016-06-01 2019-02-13 브리스톨-마이어스 스큅 컴퍼니 PET Imaging with PD-L1 Binding Polypeptides
US20190184043A1 (en) 2016-06-01 2019-06-20 Bristol-Myers Squibb Company Imaging methods using 18f-radiolabeled biologics
EP3475446A1 (en) 2016-06-27 2019-05-01 Juno Therapeutics, Inc. Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
WO2018005556A1 (en) 2016-06-27 2018-01-04 Juno Therapeutics, Inc. Mhc-e restricted epitopes, binding molecules and related methods and uses
US20190336504A1 (en) 2016-07-15 2019-11-07 Novartis Ag Treatment and prevention of cytokine release syndrome using a chimeric antigen receptor in combination with a kinase inhibitor
CA3036717A1 (en) 2016-10-03 2018-04-12 Abbott Laboratories Improved methods of assessing gfap status in patient samples
CN110225927A (en) 2016-10-07 2019-09-10 诺华股份有限公司 Chimeric antigen receptor for treating cancer
WO2018130661A1 (en) 2017-01-13 2018-07-19 Academia Sinica Reloadable hydrogel system for treating brain conditions
WO2018130660A1 (en) 2017-01-13 2018-07-19 Academia Sinica Reloadable hydrogel system for treating myocardial infarction
WO2018168999A1 (en) * 2017-03-17 2018-09-20 国立研究開発法人理化学研究所 Method for producing complex of rna molecule and peptide, and utilization thereof
WO2018175942A1 (en) 2017-03-23 2018-09-27 Abbott Laboratories Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
CA3053409A1 (en) 2017-04-15 2018-10-18 Abbott Laboratories Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
CA3053410A1 (en) 2017-04-28 2018-11-01 Abbott Laboratories Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
AU2018272054A1 (en) 2017-05-25 2019-09-26 Abbott Laboratories Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
CA3059607A1 (en) 2017-05-30 2018-12-06 Abbott Laboratories Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin i
US20190033327A1 (en) 2017-07-03 2019-01-31 Abbott Laboratories Methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood
WO2019070161A2 (en) 2017-10-04 2019-04-11 Opko Pharmaceuticals, Llc Articles and methods directed to personalized therapy of cancer
US20190242906A1 (en) 2017-12-09 2019-08-08 Abbott Laboratories Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
US20190219598A1 (en) 2017-12-09 2019-07-18 Abbott Laboratories Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1
WO2019123262A1 (en) 2017-12-18 2019-06-27 VIIV Healthcare UK (No.5) Limited Antigen binding polypeptides

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587044A (en) 1983-09-01 1986-05-06 The Johns Hopkins University Linkage of proteins to nucleic acids
DE3590766T (en) 1985-03-30 1987-04-23
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5391723A (en) * 1989-05-31 1995-02-21 Neorx Corporation Oligonucleotide conjugates
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
CA2067194C (en) * 1989-10-05 2003-03-18 Glenn Kawasaki Cell-free synthesis and isolation of novel genes and polypeptides
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
AU8498091A (en) 1990-08-02 1992-03-02 Regents Of The University Of Colorado, The Systematic polypeptide evolution by reverse translation
US5843701A (en) * 1990-08-02 1998-12-01 Nexstar Pharmaceticals, Inc. Systematic polypeptide evolution by reverse translation
US5264563A (en) 1990-08-24 1993-11-23 Ixsys Inc. Process for synthesizing oligonucleotides with random codons
ES2155822T3 (en) 1990-12-06 2001-06-01 Affymetrix Inc Compounds and their use in a binary synthesis strategy.
DE4112440C1 (en) 1991-04-16 1992-10-22 Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De
US5795747A (en) 1991-04-16 1998-08-18 Evotec Biosystems Gmbh Process for manufacturing new biopolymers
WO1993003172A1 (en) * 1991-08-01 1993-02-18 University Research Corporation Systematic polypeptide evolution by reverse translation
US5639603A (en) 1991-09-18 1997-06-17 Affymax Technologies N.V. Synthesizing and screening molecular diversity
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5652094A (en) * 1992-01-31 1997-07-29 University Of Montreal Nucleozymes
US5541061A (en) 1992-04-29 1996-07-30 Affymax Technologies N.V. Methods for screening factorial chemical libraries
US5635602A (en) 1993-08-13 1997-06-03 The Regents Of The University Of California Design and synthesis of bispecific DNA-antibody conjugates
WO1995011922A1 (en) 1993-10-29 1995-05-04 Affymax Technologies N.V. In vitro peptide and antibody display libraries
US5561043A (en) 1994-01-31 1996-10-01 Trustees Of Boston University Self-assembling multimeric nucleic acid constructs
AT243745T (en) 1994-01-31 2003-07-15 Univ Boston Libraries of polyclonal antibodies
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5627024A (en) 1994-08-05 1997-05-06 The Scripps Research Institute Lambdoid bacteriophage vectors for expression and display of foreign proteins
US5559000A (en) 1995-01-18 1996-09-24 The Scripps Research Institute Encoded reaction cassette
DE19646372C1 (en) * 1995-11-11 1997-06-19 Evotec Biosystems Gmbh Conjugates of polypeptide and encoding nucleic acid
DE69730157D1 (en) 1996-10-17 2004-09-09 Mitsubishi Chem Corp Molecule which brings together genotype and phenotype and its applications
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
GB9712512D0 (en) 1997-06-16 1997-08-20 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
US5985575A (en) 1998-05-20 1999-11-16 Wisconsin Alumni Research Foundation Tethered function assay for protein function

Also Published As

Publication number Publication date
CA2278786C (en) 2010-07-20
ES2373110T3 (en) 2012-01-31
US6214553B1 (en) 2001-04-10
DE69835143D1 (en) 2006-08-17
IL131016A (en) 2004-12-15
WO1998031700A1 (en) 1998-07-23
PT971946E (en) 2006-11-30
EP0971946A1 (en) 2000-01-19
CA2278786A1 (en) 1998-07-23
CN1251593A (en) 2000-04-26
RU2233878C2 (en) 2004-08-10
US6207446B1 (en) 2001-03-27
US6518018B1 (en) 2003-02-11
KR100566859B1 (en) 2006-04-03
AU738328B2 (en) 2001-09-13
DE69835143T2 (en) 2007-06-06
KR20000070361A (en) 2000-11-25
DK0971946T3 (en) 2006-10-30
JP2002513281A (en) 2002-05-08
EP1712623B1 (en) 2011-10-19
AT529509T (en) 2011-11-15
IL131016D0 (en) 2001-01-28
DK1712623T3 (en) 2012-02-06
US6258558B1 (en) 2001-07-10
TW589323B (en) 2004-06-01
EP1712623A2 (en) 2006-10-18
EP1712623A3 (en) 2008-10-15
ES2268763T3 (en) 2007-03-16
US6281344B1 (en) 2001-08-28
PT1712623E (en) 2011-12-21
JP3692542B2 (en) 2005-09-07
EP0971946A4 (en) 2002-12-04
EP0971946B1 (en) 2006-07-05
CN1238366C (en) 2006-01-25
HK1027577A1 (en) 2006-09-01
AU6241998A (en) 1998-08-07

Similar Documents

Publication Publication Date Title
DK1242460T3 (en) Immobilization of proteins by a polypeptide segment
DE69830497D1 (en) Library for in vitro expression of peptides or proteins
DK1003775T3 (en) Hepatitis C inhibitor peptides
DK1003850T3 (en) Inhibitors of DNA immunostimulatory sequence activity
DE69936351D1 (en) Glycosylated proteins with reduced allergenity
DK2301580T3 (en) Container with anti-VEGF antibodies
DK0981618T4 (en) Anti-Apo-2 antibody
DE69535128D1 (en) Combined sythesis of new materials
DE69837906D1 (en) Insecticides proteintoxin of xenorhabus
DE69841674D1 (en) Mixing heterologist dna sequences
DE10399023I2 (en) TFN-binding proteins
DK1355942T3 (en) GLP-1 fusion proteins
DE69833228D1 (en) Bridge zünder
DE69735376D1 (en) Fusion proteins including stress proteins to indicate an immune response
DE69836049D1 (en) Determination of nucleic acids by quenching the fluorescence
DE69834112D1 (en) Dna characterization
DE69840361D1 (en) New bone mineralization proteins, dna, vectors, expression systems
DE69838676D1 (en) New phytase
DK1000146T3 (en) 5 ′ ESTs for non-tissue-specific secreted proteins
DE69942231D1 (en) Site-specific DUAL PEGYLATION OF PROTEINS
DE69841110D1 (en) Extended cdns that code for secreted proteins
DE69840448D1 (en) 13c, 15n, 2h marked proteins for nmr structural determination and their preparation
DK0851868T3 (en) High-level expression of proteins
DE69936105D1 (en) Human tslp nucleic acids and polypeptides
DK1003781T3 (en) Interleukin-18 binding proteins, their preparation and use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0971946

Country of ref document: EP